Together, our findings explain that MRPS31 loss is a key driver of mitochondrial dysfunction and HCC aggressiveness by modulating hepatoma cell invasiveness, suggesting MRPS31 loss as a novel prognostic marker of HCC malignancy. This evidence concerns the gene MRPS31 and hepatocellular carcinoma.